Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Camulos Capital was an investment management firm based in Stamford, Connecticut, that specialized in credit-oriented strategies, distressed debt, and special situations. Founded in 2005 by Richard Brennan, a former Managing Director at Lazard, the firm initially managed several billion dollars in assets with a focus on complex credit markets and high-yield opportunities. While the firm invested across various sectors, it functioned strictly as a financial services entity rather than a biotechnology or pharmaceutical developer. Following the global financial crisis, the firm experienced significant redemptions and eventually wound down its primary operations. It is not associated with any proprietary drug development pipelines or therapeutic platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Camulos Capital.